XENE financials
Xenon Pharmaceuticals (XENE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
XENE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $7.50M | $4.96M | -$373.07M | -$345.91M | -4.36 |
| 2024 | $0.00 | -$2.56M | -$279.30M | -$234.33M | -3.01 |
| 2023 | $0.00 | -$167.51M | -$214.05M | -$182.39M | -2.73 |
| 2022 | $9.43M | $9.43M | -$129.14M | -$125.37M | -2.06 |
| 2021 | $18.44M | $18.44M | -$78.99M | -$78.88M | -1.77 |
| 2020 | $32.17M | $32.17M | -$31.30M | -$28.84M | -0.83 |
- XENE revenue was $7.50M in fiscal 2025, net income -$345.91M.
Updated 2026-11-02 23:14 UTC